NDC 0781-3239-46 - Ciprofloxacin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0781-3239
- Requested NDC
- 0781-3239-46
- Package NDCs from labels
- 0781-3239-46, 0781-3239-09
- Manufacturer
- Sandoz Inc
- Effective date
- 2015-03-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ciprofloxacin - Sandoz Inc | Sandoz Inc | 2015-03-10 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0781-3239-09 | 2020-05-07 | C162847 | 48780-1 | 9d75b9d0-c913-f424-e053-dadaa90a57ce | CIPROFLOXACIN INJECTION, USP For Intravenous Infusion |
| 0781-3239-09 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-c913-f424-e053-dadaa90a57ce | CIPROFLOXACIN INJECTION, USP For Intravenous Infusion |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0781-3239-09 | ML - Milliliter | 0781-3239 | 55d22f44-4b49-4232-93e8-0dbc9b32cbc8 | 1 | 2013-02-13 |
| 0781-3239-46 | ML - Milliliter | 0781-3239 | d50a1dd2-1999-475c-bb8b-c2f9da4f7cc0 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CIPROFLOXACIN | ACTIVE INGREDIENT | 5E8K9I0O4U | CIPROFLOXACIN INJECTION [SANDOZ INC] | 12 | |
| CIPROFLOXACIN | ACTIVE MOIETY | 5E8K9I0O4U | CIPROFLOXACIN INJECTION [SANDOZ INC] | 12 | |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | LX22YL083G | CIPROFLOXACIN INJECTION [SANDOZ INC] | 12 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | CIPROFLOXACIN INJECTION [SANDOZ INC] | 12 | |
| LACTIC ACID | INACTIVE INGREDIENT | 33X04XA5AT | CIPROFLOXACIN INJECTION [SANDOZ INC] | 12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 50% DEXTROSE | 50% DEXTROSE | HF Acquisition Co LLC, DBA HealthFirst | 763b1cb8-1151-5f59-e053-2991aa0a4e01 | 2024-02-22 | Warnings, Adverse reactions | LX22YL083G |
| DEXTROSE | DEXTROSE | HF Acquisition Co LLC, DBA HealthFirst | 75c902e8-50e7-a337-e053-2991aa0a2093 | 2024-02-19 | Warnings, Adverse reactions | LX22YL083G |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643994f-4e13-4572-e053-2991aa0a5b78 | 2023-11-14 | QTT17582CB | |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 6907bbfe-caa5-2ce4-e053-2991aa0ade8d | 2023-11-14 | QTT17582CB | |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643c518-13b2-658a-e053-2a91aa0ac5ed | 2023-11-14 | QTT17582CB | |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643e30e-1f47-09f1-e053-2991aa0ac2de | 2023-11-14 | QTT17582CB | |
| CV TOX | COCHLEARIA ARMORACIA, ECHINACEA (ANGUSTIFOLIA), LOMATIUM DISSECTUM, TABEBUIA IMPETIGINOSA, HYDRASTIS CANADENSIS, PROPOLIS, GLANDULA SUPRARENALIS BOVINE, THYMUS (SUIS), ARANEA DIADEMA, IPECACUANHA, LYCOPODIUM CLAVATUM, MURIATICUM ACIDUM, NITRICUM ACIDUM, PHOSPHORICUM ACIDUM, RHUS TOX, SILICEA, EPSTEIN-BARR VIRUS NOSODE, HERPES ZOSTER NOSODE, MORBILLINUM, POLIOMYELITIS NOSODE, HEPATITIS B NOSODE, COXSACKIE B1 NOSODE, CYTOMEGALOVIRUS NOSODE, COXSACKIE B4 NOSODE, EPSTEIN BARR VIRUS NOSODE | BioActive Nutritional, Inc. | 8ef2fb5c-1b24-46a1-8d21-a78ce0a34a87 | 2023-11-07 | Warnings | QTT17582CB |
| Ahh Sleep | COFFEA CRUDA | Micro Balance Health Products | 08ea860f-0183-8ce8-e063-6394a90a582b | 2023-10-30 | Warnings | QTT17582CB |
| Stomach Enzyme Formula | BETAINUM MURIATICUM, MURIATICUM ACIDUM, NATRUM PHOSPHORICUM, PANCREAS SUIS, STOMACH (SUIS) SYMPHYTUM OFFICINALE, PEPSINUM | Nutritional Specialties, Inc. | 992e6f61-abc9-4146-a9da-5ada4a627aa7 | 2023-10-04 | Warnings | QTT17582CB |
| AnubisMed | GLYCOLIC ACID, CITRIC ACID, LACTIC ACID, KOJIC ACID | ANUBIS COSMETICS SL | eca95dde-cb57-2ab6-e053-2995a90af84f | 2023-09-05 | Warnings | 33X04XA5AT |
| Anubis Barcelona New Even | LACTIC ACID, CITRIC ACID, GLYCOLIC ACID | ANUBIS COSMETICS SL | eaeeb6e0-5322-20c4-e053-2995a90a9fd9 | 2023-09-01 | Warnings | 33X04XA5AT |
| Pancreapar | SYZYGIUM JAMBOLANUM, GLANDULA SUPRARENALIS SUIS, HYDRASTIS CANADENSIS, HYPOPHYSIS SUIS, PANCREAS SUIS, PHASEOLUS, ACETICUM ACIDUM, LACTICUM ACIDUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, URANIUM NITRICUM | Energique, Inc. | ba9c13d0-92de-4159-8a35-215e3de50c07 | 2023-08-24 | Warnings | 33X04XA5AT |
| Heparin Sodium in Dextrose | HEPARIN SODIUM AND DEXTROSE | B. Braun Medical Inc. | 92a6f533-1a3d-4734-b413-d245592454e3 | 2023-07-31 | Warnings, Adverse reactions | LX22YL083G |
| REFL HS | ADENOSINUM TRIPHOSPHORICUM DINATRUM, NADIDUM, ARGENTUM NITRICUM, IPECACUANHA, ROBINIA PSEUDOACACIA, SULPHUR, ORIGANUM VULGARE, DUODENUM (SUIS), ESOPHAGUS (SUIS), FUNICULUS UMBILICALIS SUIS, STOMACH (SUIS), NUX VOMICA, COUMARINUM, ERYTHRAEA CENTAURIUM, PANCREATINUM, MURIATICUM ACIDUM, CITRICUM ACIDUM, FORMICUM ACIDUM, SARCOLACTICUM ACIDUM, COENZYME A, PROTEUS (MORGANI) | Deseret Biologicals, Inc. | 2fe2d3c1-1829-4a33-be8e-2bad52546f36 | 2023-07-17 | Warnings | QTT17582CB |
| Dextrose | DEXTROSE MONOHYDRATE | Medical Purchasing Solutions, LLC | 677a81e5-26ba-2a69-e053-2991aa0a101a | 2023-05-30 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Medical Purchasing Solutions, LLC | ada63d44-3b37-b65d-e053-2a95a90aa088 | 2023-05-03 | Warnings, Adverse reactions | LX22YL083G |
| Anticoagulant Citrate Dextrose A | ANHYDROUS CITRIC ACID, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Citra Labs LLC | 5bcd261e-ebba-4ecb-af22-e5aaeb04499b | 2023-02-14 | Warnings, Adverse reactions | LX22YL083G |
| Acidum Muriaticum | ACIDUM MURIATICUM | Hahnemann Laboratories, INC. | f2aad04c-5151-6cab-e053-2a95a90ad3a7 | 2023-01-19 | QTT17582CB | |
| Dextrose Monohydrate | DEXTROSE MONOHYDRATE | International Medication Systems, Limited | fcc7ac79-cd70-4f03-a4de-f051f9ca1f7d | 2022-12-20 | Warnings, Adverse reactions | LX22YL083G |
| 25% Dextrose Infant | 25% DEXTROSE INFANT | HF Acquisition Co. LLC, DBA Health First | 73d04839-a2bb-65dd-e053-2991aa0a82ca | 2022-12-09 | Warnings, Adverse reactions | LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.